EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Control of Synaptotagmin‐1 Trafficking by SV2A —Mechanism and Consequences for Presynaptic Function and Dysfunction

James A Hogg iD, Michael A Cousin iD

Journal of Neurochemistry · 2025-01 · 169 (1)

DOI: 10.1111/jnc.16308 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 24.01.2025. Verfasst von James A Hogg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Discovery Brain Sciences, Hugh Robson Building, George Square, University of Edinburgh, Edinburgh, Scotland, UK. Hauptthemen laut MEDLINE: Synaptotagmin I, Nerve Tissue Proteins, Presynaptic Terminals, Membrane Glycoproteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Epilepsy Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synaptic vesicle protein 2A (SV2A) is an abundant synaptic vesicle cargo with an as yet unconfirmed role in presynaptic function. It is also heavily implicated in epilepsy, firstly being the target of the leading anti‐seizure medication levetiracetam and secondly with loss of function mutations culminating in human disease. A range of potential presynaptic functions have been proposed for SV2A; however its interaction with the calcium sensor for synchronous neurotransmitter release, synaptotagmin‐1 (Syt1), has received particular attention over the past decade. In this review we will assess the evidence that the primary role of SV2A is to control the expression and localisation of Syt1 at the presynapse. This will integrate biochemical, cell biological and physiological studies where the interaction, trafficking and functional output of Syt1 is altered by SV2A. The potential for SV2A‐dependent epilepsy to be a result of dysfunctional Syt1 expression and localisation is also discussed. Finally, a series of key open questions will be posed that require resolution before a definitive role for SV2A in Syt1 function in health and disease can be confirmed. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synaptotagmin INerve Tissue ProteinsPresynaptic TerminalsMembrane GlycoproteinsHumansAnimalsProtein TransportEpilepsySynaptic Vesicles

Stichwörter der Autor:innen

SV2Aendocytosisepilepsypresynapsesynaptic vesiclesynaptotagmin‐1

Substanzen

Synaptotagmin INerve Tissue ProteinsMembrane GlycoproteinsSV2A protein, human

Autor:innen und Institutionen

  • Centre for Discovery Brain Sciences, Hugh Robson Building, George Square, University of Edinburgh, Edinburgh, Scotland, UK.
  • Simons Initiative for the Developing Brain, Hugh Robson Building, George Square, University of Edinburgh, Edinburgh, Scotland, UK.
  • Muir Maxwell Epilepsy Centre, Hugh Robson Building, George Square, University of Edinburgh, Edinburgh, Scotland, UK.

ORCID-Profile: James A Hogg, Michael A Cousin

Förderung

  • Epilepsy Research UK

Zitieren

APA

Hogg, J. A., & Cousin, M. A. (2025). Control of Synaptotagmin‐1 Trafficking by SV2A —Mechanism and Consequences for Presynaptic Function and Dysfunction. Journal of Neurochemistry, 169(1). https://doi.org/10.1111/jnc.16308

Vancouver

Hogg JA, Cousin MA. Control of Synaptotagmin‐1 Trafficking by SV2A —Mechanism and Consequences for Presynaptic Function and Dysfunction. Journal of Neurochemistry. 2025;169(1). doi:10.1111/jnc.16308

BibTeX
@article{Hogg2025,
  author = {Hogg, James A and Cousin, Michael A},
  title = {Control of Synaptotagmin‐1 Trafficking by SV2A —Mechanism and Consequences for Presynaptic Function and Dysfunction},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {1},
  doi = {10.1111/jnc.16308}
}
Kostenlos starten →